Skip to main navigation Skip to search Skip to main content

Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach

  • Rajal B. Shah*
  • , Gladell P. Paner
  • , Liang Cheng
  • , Angelo M. De Marzo
  • , Cristina Magi-Galluzzi
  • , Murali Varma
  • , Ming Zhou
  • , Ali Amin
  • , Mahul B. Amin
  • , Manju Aron
  • , Isabela W. Cunha
  • , Jonathan I. Epstein
  • , Samson W. Fine
  • , Aiman Haider
  • , Kenneth A. Iczkowski
  • , James G. Kench
  • , Lakshmi Priya Kunju
  • , Sambit K. Mohanty
  • , Rodolfo Montironi
  • , George J. Netto
  • Chin Chen Pan, Priya Rao, John R. Srigley, Guido Sauter, Puay Hoon Tan, Toyonori Tsuzuki, Theodorus H. van der Kwast, Geert J. van Leenders, Glen Kristiansen
*Corresponding author for this work
  • University of Texas Southwestern Medical Center
  • The University of Chicago
  • Alpert Medical School of Brown University
  • Johns Hopkins Medical Institutions
  • University of Alabama at Birmingham
  • Cardiff & Vale University Health Board
  • Icahn School of Medicine at Mount Sinai
  • University of Tennessee Health Science Center
  • University of Southern California
  • SB Do Campo
  • Integrate Medical Professionals Pathology
  • Memorial Sloan-Kettering Cancer Center
  • University College London Hospitals NHS Foundation Trust
  • University of California at Davis
  • Royal Prince Alfred Hospital
  • University of Michigan, Ann Arbor
  • CORE Diagnostics
  • Marche Polytechnic University
  • University of Pennsylvania
  • Veterans General Hospital-Taipei
  • University of Texas MD Anderson Cancer Center
  • University of Toronto
  • University Medical Center Hamburg-Eppendorf
  • Luma Medical Center
  • Aichi Medical University
  • University Hospital Bonn

Research output: Contribution to journalEditorialAcademicpeer-review

9 Citations (Scopus)
94 Downloads (Pure)

Abstract

The goal of this white paper is to help in identifying a path towards a meaningful multidisciplinary solution to the pervasive problem of overdiagnosis of indolent prostate cancer (PC) and its downstream negative effects. Our emphasis is not on the renaming debate for grade group (GG) 1 PC, but on reviewing the evidence base regarding the current state, limitations, gaps, and future directions for detection of indolent PC. We explain why the optimal diagnosis of indolent PC—defined as a low-volume, well-differentiated acinar neoplasm with invasive histologic features that do not spread outside the prostate, become symptomatic, or shorten a patient’s life if left untreated—requires coordination among clinicians, radiologists, and pathologists rather than relying on pathologists alone. We also show why clinically insignificant PC and indolent PC, despite considerable overlap, do not necessarily mean the same entity.
Original languageEnglish
Pages (from-to)8-10
Number of pages3
JournalEuropean Urology
Volume88
Issue number1
DOIs
Publication statusPublished - Jul 2025

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Genitourinary Pathology Society and International Society of Urological Pathology White Paper on Defining Indolent Prostate Cancer: Call for a Multidisciplinary Approach'. Together they form a unique fingerprint.

Cite this